Cover Image
市場調查報告書

CountryFocus:新加坡的醫療·規定·醫療費給付制度狀況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

出版商 GlobalData 商品編碼 321243
出版日期 內容資訊 英文 238 Pages
訂單完成後即時交付
價格
Back to Top
CountryFocus:新加坡的醫療·規定·醫療費給付制度狀況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore
出版日期: 2014年11月28日 內容資訊: 英文 238 Pages
簡介

新加坡的人口由於平均壽命的改善等影響,2008年為480萬人,到2013年持續增加到540萬人。各個因素加起來,醫藥品市場也從2008年為4億8900萬美金,持續增加到2013年的7億6100萬美金,這段期間以年平均成長率(CAGR)9.3%這個擴大趨勢持續成長。此外,推計到2014年市場規模為7億7600萬美金,2020年將達到8億7300萬美金,2014∼2020年的CAGR(年平均成長率)為2.0%。同時,醫療技術部門的生產額在2011年達到43億新幣(34億美金),到2015年預測將更進一步擴大到50億新幣(40億美金)的規模。政府積極的支援政策及大學熱烈地研究活動,有助於醫療相關市場的正向成長。

本報告提供新加坡的醫療相關市場趨勢,及醫療費給付制度和其他相關法規·制度的分析,提供醫藥品產業·醫療設備產業的整體結構與趨勢,醫療費給付制度及其週邊的保險市場趨勢,醫療法規當局結構和各種法規概要,彙整新加坡經濟·社會相關宏觀指標(醫療基礎設施等),今後的市場機會與課題的資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 醫藥品·醫療設備市場概要

  • 醫藥品市場
    • 市場概要
    • 醫藥品的進出口
    • 供給流通管道
    • 市場分類
    • 主要的疾病領域
    • 主要參與企業
  • 醫療設備市場
    • 市場概要
  • 市場推動因素與阻礙
    • 推動因素
    • 進入障礙

第4章 市場進入

  • 醫療費給付·保險費支付者狀況
    • 醫療制度概要
    • 醫療費給付流程
    • 保險經營者概要
    • 患者負擔佔醫療費用支出的比率
    • 醫療服務的價格趨勢
    • 藥價政策
  • 法規情形
    • 法規當局概要
    • 醫藥品的市售核准過程
    • 新醫療設備的認證過程
    • 醫療設備新產品的認證過程
    • 進出口
    • 知識產權
    • 臨床實驗的相關法規
    • 醫藥品的廣告相關法規
    • 藥局的相關法規
    • 標籤·包裝相關法規

第5章 各國分析

  • 政治環境
    • 政治結構
    • 目前政治環境相關分析
    • 醫療相關政策的配合措施
  • 經濟形勢
  • 經濟指標
    • 國內生產總值(GDP)
    • 國民所得毛額
    • 通貨膨脹
    • 匯率
    • 海外直接投資
    • 外匯儲備金
    • 貿易收支
    • 政府結構平衡
    • 國債發行總額
    • 主要產業
  • 人口統計
    • 人口
    • 教育及識字率
    • 工作情形
    • 疾病負擔
  • 醫療基礎設施
    • 醫療設備
    • 醫療參數
    • 環境衛生
    • 醫療人力資源
  • 醫療費
    • 概要
    • 官方/民間部門的佔有率
    • 醫療費用支出的主要的內容
    • 醫藥品的研究開發的支出額
  • 產業團體
  • 展覽會

第6章 市場機會及課題

  • 市場機會
  • 課題

第7章 附錄

圖表一覽

目錄
Product Code: GDHC0074CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Singapore's population grew from 4.8 million in 2008 to 5.4 million in 2013, mainly due to the increase in the life expectancy (DoS, 2014). The value of the pharmaceuticals market increased from $489m in 2008 to $761m in 2013 at a Compound Annual Growth Rate (CAGR) of 9.3%, and this value is expected to increase further from $776m in 2014 to $873m in 2020 at a CAGR of 2.0% (Tarn et al., 2008; DoS, 2014; EDB, 2014c). In 2011, the output of the medical technology sector was SGD4.3 billion ($3.4 billion), which is expected to increase to SGD5 billion ($4 billion) in 2015 (EDB, 2014a).

These positive growth trends can primarily be attributed to -

  • Government initiatives
  • Universal healthcare coverage

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Singapore, and includes -

  • Overview of the pharmaceutical market including size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Haw Par Corporation, SciGen, Pfizer, Novartis and GlaxoSmithKline
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Singaporean healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Singapore's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Singapore's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Singapore's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Market

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Major Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Price Trends in the Healthcare Sector
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Government Structural Balance
    • 5.3.9. Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Share of Public and Private Sectors
    • 5.6.3. Major Components of Healthcare Spending
    • 5.6.4. Spending in Pharmaceutical Research and Development
  • 5.7. Trade Associations
    • 5.7.1. The Singapore Association of Pharmaceutical Industries
    • 5.7.2. The Singapore Medical Association
    • 5.7.3. The Society for Emergency Medicine in Singapore
    • 5.7.4. The Pharmaceutical Society of Singapore
    • 5.7.5. The Healthcare Quality Society of Singapore
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Singapore, Revenue ($m), 2008-2013
  • Table 2: Pharmaceutical Market, Singapore, Revenue Forecast ($m), 2014-2020
  • Table 3: Pharmaceutical Market, Singapore, Exports and Imports ($bn), 2008-2013
  • Table 4: Pharmaceutical Market, Haw Par, Global, Major Products, 2014
  • Table 5: Pharmaceutical Market, SciGen, Global, Major Products, 2014
  • Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014
  • Table 8: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 9: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018
  • Table 10: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013
  • Table 11: Pharmaceutical Market, GlaxoSmithKline, Global, Late-Stage Pipeline, 2014
  • Table 12: Market Access, Singapore, Medisave Wage Contribution (%), 2014
  • Table 13: Market Access, Singapore, MediShield Premium Payment Scheme by Age Group ($), 2014
  • Table 14: Market Access, Singapore, Medisave-Approved Integrated Shield Plans Withdrawal Limit by Age Group ($), 2014
  • Table 15: Market Access, Singapore, Healthcare Spending, Out-of-Pocket Expenditure (%), 2008-2013
  • Table 16: Market Access, Singapore, Price of Pharmaceutical Products, Change in Average Price of Medicines (%), 2008-2013
  • Table 17: Market Access, Singapore, Registration Dossier Format, 2014
  • Table 18: Market Access, Singapore, Registration Dossier Format, 2014
  • Table 19: Market Access, Singapore, Registration Dossier Format, 2014
  • Table 20: Market Access, Singapore, GMP Certificate Fees for Medicinal Products and APIs ($), 2014
  • Table 21: Market Access, Singapore, Manufacturer's License Fees for Medicinal Products ($), 2014
  • Table 22: Market Access, Singapore, Manufacturer's License Fees for Medicinal Products ($), 2014
  • Table 23: Market Access, Singapore, Wholesale Dealer's License Fees for Medicinal Products ($), 2014
  • Table 24: Market Access, Singapore, Patent Co-operation Treaty (PCT), International Application Process, 2014
  • Table 25: Market Access, Singapore, Patent Filing Fees and Charges SGD ($), 2014
  • Table 26: Market Access, Singapore, Clinical Trial Certificates Issued, 2008-2013
  • Table 27: Market Access, Singapore, Clinical Trials by Therapeutic Area (%), 2013
  • Table 28: Market Access, Singapore, Target Processing Timelines of Clinical Trial, 2014
  • Table 29: Market Access, Singapore, Fees for Advertisement Permit ($), 2010
  • Table 30: Market Access, Singapore, Fees for Advertisement Permit ($), 2014
  • Table 31: Market Access, Singapore, Labeling Requirements, 2014
  • Table 32: Economic Indicators, Singapore, Gross Domestic Product per Capita ($), 2008-2013
  • Table 33: Economic Indicators, Singapore, Gross Domestic Product per Capita ($), Forecast, 2014-2020
  • Table 34: Economic Indicators, Singapore, Gross Domestic Product Annual Growth (%), 2008-2013
  • Table 35: Economic Indicators, Singapore, Gross Domestic Product Annual Growth (%), Forecast, 2014-2020
  • Table 36: Economic Indicators, Singapore, Gross National Income per Capita ($), 2008-2013
  • Table 37: Economic Indicators, Singapore, Consumer Price Index, 2008-2013
  • Table 38: Economic Indicators, Singapore, Average Consumer Price Index, Forecast, 2014-2020
  • Table 39: Economic Indicators, Singapore, Average Consumer Price Index, Annual Change (%), 2008-2013
  • Table 40: Economic Indicators, Singapore, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020
  • Table 41: Economic Indicators, Singapore, Currency Exchange Rate (SGD/$), 2008-2013
  • Table 42: Economic Indicators, Singapore, Foreign Direct Investment ($bn), 2008-2013
  • Table 43: Economic Indicators, Singapore, Foreign Exchange Reserves ($bn), 2008-2013
  • Table 44: Economic Indicators, Singapore, Imports of Goods and Services ($bn), 2008-2013
  • Table 45: Economic Indicators, Singapore, Exports of Goods and Services ($bn), 2008-2013
  • Table 46: Economic Indicators, Singapore, General Government Structural Balance ($bn), 2008-2013
  • Table 47: Economic Indicators, Singapore, General Government Gross Debt ($bn), 2008-2013
  • Table 48: Economic Indicators, Singapore, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013
  • Table 49: Demographics, Singapore, Population (million), 2008-2013
  • Table 50: Demographics, Singapore, Population Forecast (million), 2014-2020
  • Table 51: Demographics, Singapore, Population Distribution by Age Group (%), 2008-2013
  • Table 52: Demographics, Singapore, Population Distribution by Age Group Forecast (%), 2014-2020
  • Table 53: Demographics, Singapore, Births (per 1,000 Population), 2008-2013
  • Table 54: Demographics, Singapore, Mortality (per 1,000 Population), 2008-2013
  • Table 55: Demographics, Singapore, Major Causes of Mortality ('000), 2008
  • Table 56: Demographics, Singapore, Children Under Five Mortality Rate (per 1,000 Live Births), 2008-2013
  • Table 57: Demographics, Singapore, Immunization Rate (%), 2008-2013
  • Table 58: Demographics, Singapore, Major Causes of Male Mortality (per 1,000 Population), 2008
  • Table 59: Demographics, Singapore, Major Causes of Female Mortality (per 1,000 Population), 2008
  • Table 60: Demographics, Singapore, Gender Ratio (M/F), 2008-2013
  • Table 61: Demographics, Singapore, Life Expectancy at Birth (Years), 2008-2013
  • Table 62: Demographics, Singapore, Student Enrollment by Level of Education (%), 2013
  • Table 63: Demographics, Singapore, Unemployment Rate (%), 2008-2013
  • Table 64: Demographics, Singapore, Major Causes of Patient Discharge (%), 2012
  • Table 65: Demographics, Singapore, Major Diseases, DALYs (per 100,000 Population), 2004
  • Table 66: Healthcare Infrastructure, Singapore, Hospitals, 2008-2013
  • Table 67: Healthcare Infrastructure, Singapore, Public and Private Hospitals, 2008-2013
  • Table 68: Healthcare Infrastructure, Singapore, Hospitals Beds (per 1,000 Population), 2008-2013
  • Table 69: Healthcare Infrastructure, Singapore, Beds by Type of Hospital, 2008-2013
  • Table 70: Healthcare Infrastructure, Singapore, Number of Physicians (per 10,000 Population), 2008-2013
  • Table 71: Healthcare Infrastructure, Singapore, PM10 (µg/m³), 2008-2013
  • Table 72: Healthcare Infrastructure, Singapore, CO2 Emissions (Million Metric Tons), 2008-2013
  • Table 73: Healthcare Infrastructure, Singapore, Water Pollutants (Million Metric Tons), 2008-2013
  • Table 74: Healthcare Infrastructure, Singapore, Waste Generated (million Tons), 2008-2013
  • Table 75: Healthcare Infrastructure, Singapore, Waste Handling Methods Share (%), 2013
  • Table 76: Healthcare Infrastructure, Singapore, Waste Recycling Share by Type of Waste (%), 2013
  • Table 77: Healthcare Infrastructure, Singapore, Nurses (per 1,000 Population), 2008-2013
  • Table 78: Healthcare Infrastructure, Singapore, Midwives (per 1,000 Population), 2008-2013
  • Table 79: Healthcare Infrastructure, Singapore, Dentists (per 1,000 Population), 2008-2013
  • Table 80: Healthcare Infrastructure, Singapore, Pharmacists (per 1,000 Population), 2008-2013
  • Table 81: Healthcare Infrastructure, Singapore, Healthcare Expenditure (% of GDP), 2008-2013
  • Table 82: Healthcare Infrastructure, Singapore, Public-Private Share (%), 2008-2013
  • Table 83: Healthcare Infrastructure, Singapore, Share of Expenditure of Major Components of Healthcare Spending (%), 2014
  • Table 84: Healthcare Infrastructure, Singapore, R&D Expenditure ($m), 2008-2013
  • Table 85: Trade Fairs, Singapore, Major Healthcare Trade Fairs, 2014

List of Figures

  • Figure 1: Pharmaceutical Market, Singapore, Revenue ($m), 2008-2013
  • Figure 2: Pharmaceutical Market, Singapore, Revenue Forecast ($m), 2014-2020
  • Figure 3: Pharmaceutical Market, Singapore, Exports and Imports ($bn), 2008-2013
  • Figure 4: Pharmaceutical Market, Singapore, Distribution Channels, 2014
  • Figure 5: Healthcare Market, Singapore, Drivers and Barriers, 2014
  • Figure 6: Market Access, Singapore, Healthcare Insurance System, 2014
  • Figure 7: Market Access, Singapore, Healthcare Financing System, 2014
  • Figure 8: Market Access, Singapore, Healthcare Spending, Out-of-Pocket Expenditure (%), 2008-2013
  • Figure 9: Market Access, Singapore, Price of Pharmaceutical Products, Change in Average Price of Medicines (%), 2008-2013
  • Figure 10: Market Access, Singapore, Structure of the Ministry of Health, 2014
  • Figure 11: Market Access, Singapore, Structure of the Health Sciences Authority, 2014
  • Figure 12: Market Access, Singapore, New Drug Application Types, 2014
  • Figure 13: Market Access, Singapore, New Drug Approval Process, 2014
  • Figure 14: Market Access, Singapore, Licensing Process for Manufacturing, 2014
  • Figure 15: Market Access, Singapore, Licensing Process for Import/Export, 2014
  • Figure 16: Market Access, Singapore, National Patent Approval Process, 2014
  • Figure 17: Market Access, Singapore, PCT National Phase Entry Process, 2014
  • Figure 18: Market Access, Singapore, International Patent Approval Process, 2014
  • Figure 19: Market Access, Singapore, National Trademark Approval Process, 2014
  • Figure 20: Market Access, Singapore, International Trademark Approval Process, 2014
  • Figure 21: Market Access, Singapore, Clinical Trial Certificates Issued, 2008-2013
  • Figure 22: Market Access, Singapore, Clinical Trials by Therapeutic Area (%), 2013
  • Figure 23: Market Access, Singapore, Clinical Trial Approval Process, 2014
  • Figure 24: Market Access, Singapore, Pharmacy Regulations, 2014
  • Figure 25: Economic Indicators, Singapore, Gross Domestic Product per Capita ($), 2008-2013
  • Figure 26: Economic Indicators, Singapore, Gross Domestic Product per Capita ($), Forecast, 2014-2020
  • Figure 27: Economic Indicators, Singapore, Gross Domestic Product Annual Growth (%), 2008-2013
  • Figure 28: Economic Indicators, Singapore, Gross Domestic Product Annual Growth (%), Forecast, 2014-2020
  • Figure 29: Economic Indicators, Singapore, Gross National Income per Capita ($), 2008-2013
  • Figure 30: Economic Indicators, Singapore, Consumer Price Index, 2008-2013
  • Figure 31: Economic Indicators, Singapore, Average Consumer Price Index, Forecast, 2014-2020
  • Figure 32: Economic Indicators, Singapore, Average Consumer Price Index, Annual Change (%), 2008-2013
  • Figure 33: Economic Indicators, Singapore, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020
  • Figure 34: Economic Indicators, Singapore, Currency Exchange Rate (SGD/$), 2008-2013
  • Figure 35: Economic Indicators, Singapore, Foreign Direct Investment ($bn), 2008-2013
  • Figure 36: Economic Indicators, Singapore, Foreign Exchange Reserves ($bn), 2008-2013
  • Figure 37: Economic Indicators, Singapore, Imports of Goods and Services ($bn), 2008-2013
  • Figure 38: Economic Indicators, Singapore, Exports of Goods and Services ($bn), 2008-2013
  • Figure 39: Economic Indicators, Singapore, Government Structural Balance ($bn), 2008-2013
  • Figure 40: Economic Indicators, Singapore, General Government Gross Debt ($bn), 2008-2013
  • Figure 41: Economic Indicators, Singapore, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013
  • Figure 42: Demographics, Singapore, Population (million), 2008-2013
  • Figure 43: Demographics, Singapore, Population Forecast (million), 2014-2020
  • Figure 44: Demographics, Singapore, Population Distribution by Age Group (%), 2008-2013
  • Figure 45: Demographics, Singapore, Population Distribution by Age Group Forecast (%), 2014-2020
  • Figure 46: Demographics, Singapore, Births (per 1,000 Population), 2008-2013
  • Figure 47: Demographics, Singapore, Mortality (per 1,000 Population), 2008-2013
  • Figure 48: Demographics, Singapore, Major Causes of Mortality ('000), 2008
  • Figure 49: Demographics, Singapore, Children Under Five, Mortality Rate (per 1,000 Live Births), 2008-2013
  • Figure 50: Demographics, Singapore, Immunization Rate (%), 2008-2013
  • Figure 51: Demographics, Singapore, Major Causes of Male Mortality (per 1,000 Population), 2008
  • Figure 52: Demographics, Singapore, Major Causes of Female Mortality (per 1,000 Population), 2008
  • Figure 53: Demographics, Singapore, Gender Ratio (M/F), 2008-2013
  • Figure 54: Demographics, Singapore, Life Expectancy at Birth (Years), 2008-2013
  • Figure 55: Demographics, Singapore, Student Enrollment by Level of Education (%), 2013
  • Figure 56: Demographics, Singapore, Unemployment Rate (%), 2008-2013
  • Figure 57: Demographics, Singapore, Major Causes of Patient Discharge (%), 2012
  • Figure 58: Demographics, Singapore, Major Diseases, DALYs (per 100,000 Population), 2004
  • Figure 59: Healthcare Infrastructure, Singapore, Hospitals, 2008-2013
  • Figure 60: Healthcare Infrastructure, Singapore, Public and Private Hospitals, 2008-2013
  • Figure 61: Healthcare Infrastructure, Singapore, Hospitals Beds (per 1,000 Population), 2008-2013
  • Figure 62: Healthcare Infrastructure, Singapore, Beds by Type of Hospital, 2008-2013
  • Figure 63: Healthcare Infrastructure, Singapore, Number of Physicians (per 10,000 Population), 2008-2013
  • Figure 64: Healthcare Infrastructure, Singapore, PM10 (µg/m³), 2008-2013
  • Figure 65: Healthcare Infrastructure, Singapore, CO2 Emissions (Million Metric Tons), 2008-2013
  • Figure 66: Healthcare Infrastructure, Singapore, Water Pollutants (Million Metric Tons), 2008-2013
  • Figure 67: Healthcare Infrastructure, Singapore, Waste Generated (million Tons), 2008-2013
  • Figure 68: Healthcare Infrastructure, Singapore, Waste Handling Methods Share (%), 2013
  • Figure 69: Healthcare Infrastructure, Singapore, Waste Recycling Share by Type of Waste (%), 2013
  • Figure 70: Healthcare Infrastructure, Singapore, Nurses (per 1,000 Population), 2008-2013
  • Figure 71: Healthcare Infrastructure, Singapore, Midwives (per 1,000 Population), 2008-2013
  • Figure 72: Healthcare Infrastructure, Singapore, Dentists (per 1,000 Population), 2008-2013
  • Figure 73: Healthcare Infrastructure, Singapore, Pharmacists (per 1,000 Population), 2008-2013
  • Figure 74: Healthcare Infrastructure, Singapore, Healthcare Expenditure (% of GDP), 2008-2013
  • Figure 75: Healthcare Infrastructure, Singapore, Public-Private Share (%), 2008-2013
  • Figure 76: Healthcare Infrastructure, Singapore, Share of Expenditure of Major Components of Healthcare Spending (%), 2014
  • Figure 77: Healthcare Infrastructure, Singapore, R&D Expenditure ($m), 2008-2013
  • Figure 78: Healthcare Market, Singapore, Opportunities and Challenges, 2014
Back to Top